Trademark: 78943013
Word
SERAPIS
Status
Dead
Status Code
606
Status Date
Thursday, December 13, 2007
Serial Number
78943013
Mark Type
4000
Filing Date
Wednesday, August 2, 2006
Published for Opposition
Tuesday, March 20, 2007
Abandoned Date
Thursday, December 13, 2007

Trademark Owner History
Rifai, Abdalla - Owner At Publication

Classifications
5 Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cells for medical or clinical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, lipid lowering agents

Trademark Events
Jan 23, 2008
Abandonment Notice Mailed - No Use Statement Filed
Dec 20, 2007
Abandonment - No Use Statement Filed
Jun 12, 2007
Noa Mailed - Sou Required From Applicant
Jun 12, 2007
Assigned To Examiner
Mar 20, 2007
Published For Opposition
Feb 28, 2007
Notice Of Publication
Feb 5, 2007
Law Office Publication Review Completed
Feb 5, 2007
Assigned To Lie
Jan 3, 2007
Approved For Pub - Principal Register
Dec 27, 2006
Assigned To Examiner
Aug 8, 2006
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24